Dexcom (DXCM) Receivables - Other (2018 - 2025)
Dexcom (DXCM) has disclosed Receivables - Other for 8 consecutive years, with $16.9 million as the latest value for Q4 2025.
- Quarterly Receivables - Other rose 11.18% to $16.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $16.9 million through Dec 2025, up 11.18% year-over-year, with the annual reading at $16.9 million for FY2025, 11.18% up from the prior year.
- Receivables - Other for Q4 2025 was $16.9 million at Dexcom, up from $16.6 million in the prior quarter.
- The five-year high for Receivables - Other was $17.0 million in Q2 2025, with the low at $8.0 million in Q4 2023.
- Average Receivables - Other over 5 years is $11.7 million, with a median of $10.2 million recorded in 2022.
- The sharpest move saw Receivables - Other decreased 16.22% in 2022, then skyrocketed 90.0% in 2024.
- Over 5 years, Receivables - Other stood at $9.6 million in 2021, then decreased by 6.25% to $9.0 million in 2022, then decreased by 11.11% to $8.0 million in 2023, then surged by 90.0% to $15.2 million in 2024, then rose by 11.18% to $16.9 million in 2025.
- According to Business Quant data, Receivables - Other over the past three periods came in at $16.9 million, $16.6 million, and $17.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.